Nascent Pharma Holdings, Inc.
NASC
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.49M
Close$
Share Statistics
| Market cap | $1.49 Million |
|---|---|
| Enterprise Value | $10.50 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 124.11% |
|---|---|
| Return on Assets | -654.43% |
| Return on Invested Capital | 98.04% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 10.7 |
| Enterprise Value to EBIT | -1.09 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.86 |
| Debt to Equity | -0.92 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Can B Corp
12 employees
CEO: Marco Alfonsi Nascent Pharma Holdings, Inc. is primarily engaged in both protecting and bringing to market intellectual property pertaining to cannabis. Beyond this, the company also manufactures superfood beverage mixes, which are marketed under its ...